Day-to-day variation in plasma interleukin-6 concentrations in older adults

Cytokine

Volumn 47, Issue 3, 2009, Pages 162-165

  Picotte, Mindi ^a   Campbell, Christina Gayer ^b   Thorland, William G ^c  

^a MONTANA STATE UNIVERSITY   (United States)

^b IOWA STATE UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

Cytokine; Inflammation; Inter variability; Interleukin 6; Intra variability

Indexed keywords

INTERLEUKIN 6;

ADULT; AGED; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NORMAL HUMAN; NUTRITION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REFERENCE VALUE;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; POSTMENOPAUSE; PROSPECTIVE STUDIES;

EID: 68949097508     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2009.05.007     Document Type: Article

References (30)

1. Cesari M., Penninx B.W., Newman A.B., Kritchevsky S.B., Nicklas B.J., Sutton-Tyrell K., et al. Inflammatory markers and cardiovascular disease (The Health, Aging, and Body Composition [Health ABC] Study). Am J Cardiol 92 (2003) 522-528
2. Thakore A.H., Guo C., Larson M.G., Corey D., Wang T.J., Vasan R.S., et al. Association of multiple inflammatory markers with carotid intimal medial thickness and stenosis (from the Framingham Heart Study). Am J Cardiol 99 (2007) 1598-1602
3. Erlinger T.P., Platz E.A., Rifai N., and Helzlsouer K.J. C-reactive protein and the risk of incident colorectal cancer. JAMA 291 (2004) 585-590
4. Shariat S.F., Andrews B., Kattan M.W., Kim J., Wheeler T.M., and Slawin K.M. Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis. Urology 58 (2001) 1008-1015
5. Il'yasova D., Colbert L.H., Harris T.B., Newman A.B., Bauer D.C., Satterfield S., et al. Circulating levels of inflammatory markers and cancer risk in the Health Aging and Body Composition cohort. Cancer Epidemiol Biomarkers Prev 14 (2005) 2413-2418
6. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J.S., Humphries S., et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102 (1998) 1369-1376
7. Festa A., D'Agostino Jr. R., Williams K., Karter A.J., Mayer-Davis E.J., Tracy R.P., et al. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obesity Relat Metab Disord 25 (2001) 1407-1415
8. Malavazos A.E., Corsi M.M., Ermetici F., Coman C., Sardanelli F., Rossi A., et al. Proinflammatory cytokines and cardiac abnormalities in uncomplicated obesity: relationship with abdominal fat deposition. Nutr Metab Cardiovasc Dis 17 (2007) 294-302
9. Festa A., D'Agostino Jr. R., Tracy R.P., and Haffner S.M. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 51 (2002) 1131-1137
10. Schmidt M.I., Duncan B., Sharrett A.R., Lindberg G., Savage P.J., Offenbacher S., et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet 353 (1999) 1649-1652
11. Pradhan A.D., Manson J.E., Rifai N., Buring J.E., and Ridker P.M. C-reactive protein, interleukin-6, and risk of developing type 2 diabetes mellitus. JAMA 286 (2001) 327-334
12. Ershler W.B., Sun W.H., Binkley N., Gravenstein S., Volk M.J., Kamoske G., et al. Interleukin-6 and aging: blood levels and mononuclear cell production increase with advancing age and in vitro production is modifiable by dietary restriction. Lymphokine Cytokine Res 12 (1993) 225-230
13. Von Kanel R., Kudielka B.M., Metzenthin P., Helfricht S., Preckel D., Haeberli A., et al. Aspirin, but not propranolol, attenuates the acute stress-induced increase in circulating levels of interleukin-6: a randomized, double-blind, placebo-controlled study. Brain Behav Immun 22 (2008) 150-157
14. Trebble T., Arden N.K., Stroud M.A., Wootton S.A., Burdge G.C., Miles E.A., et al. Inhibition of tumour necrosis factor-α and interleukin-6 production by mononuclear cells following dietary fish-oil supplementation in healthy men and response to antioxidant co-supplementation. Br J Nutr 90 (2003) 405-412
15. Volpato S., Pahor M., Ferrucci L., Simonsick E.M., Guralnik J.M., Kritchevsky S.B., et al. Relationship of alcohol intake with inflammatory markers and plasminogen activator inhibitor-1 in well-functioning older adults: the Health, Aging, and Body Composition study. Circulation 109 (2004) 607-612
16. Imhof A., Froehlich M., Brenner H., Boeing H., Pepys M.B., and Koenig W. Effect of alcohol consumption on systemic markers of inflammation. Lancet 357 (2001) 763-767
17. Dugue B., and Leppanen E. Short-term variability in the concentration of serum interleukin-6 and its soluble receptor in subjectively healthy persons. Clin Chem Lab Med 36 (1998) 323-325
18. Blackburn P., Despres J.P., Lamarche B., Tremblay A., Bergeron J., Lemieux I., et al. Postprandial variations of plasma inflammatory markers in abdominally obese men. Obesity 14 (2006) 1747-1754
19. Lundman P., Boquist S., Samnegard A., Bennermo M., Held C., Ericsson C., et al. A high-fat meal is accompanied by increased plasma interleukin-6 concentrations. Nutr Metab Cardiovasc Dis 17 (2007) 195-202
20. Moldoveanu A.I., Shephard R.J., and Shek P.N. Exercise elevates plasma levels but not gene expression of IL-1β, IL-6, and TNF-α in blood mononuclear cells. J Appl Physiol 89 (2000) 1499-1504
21. Colbert L.H., Visser M., Simonsick E.M., Tracy R.P., Newman A.B., Kritchevsky S.B., et al. Physical activity, exercise, and inflammatory markers in older adults: findings from the Health, Aging, and Body Composition study. J Am Geriatr Soc 52 (2004) 1098-1104
22. Lacher D.A., Hughes J.P., and Carroll M.D. Estimate of biological variation of laboratory analytes based on the Third National Health and Nutrition Examination Survey. Clin Chem 51 (2005) 450-452
23. Harris E.K. Statistical principles underlying analytic goal-setting in clinical chemistry. Am J Clin Pathol 72 (1979) 374-382
24. Fraser C.G. Biological variation: from principles to practice (2001), American Association for Clinical Chemistry, Washington, DC p. 106-7
25. Ho G.Y.F., Xue X., Burk R.D., Kaplan R.C., Cornell E., and Cushman M. Variability of serum levels of tumor necrosis factor-alpha, interleukin 6, and soluble interleukin 6 receptor over 2 years in young women. Cytokine 30 (2005) 1-6
26. Angstwurm M.W.A., Gartner R., and Ziegler-Heitbrock H.W. Cyclic plasma IL-6 levels during normal menstrual cycle. Cytokine 9 (1997) 370-374
27. Konecna L., Yan M.S., Miller L.E., Scholmerich J., Falk W., and Straub R.H. Modulation of IL-6 production during the menstrual cycle in vivo and in vitro. Brain Behav Immun 14 (2000) 49-61
28. Cava F., Gonzalez C., Pascual M.J., Navajo J.A., and Gonzalez-Buitrago J.M. Biological variation of interleukin-6 (IL-6) and soluble interleukin 2 receptor (sILR2) in serum of healthy individuals. Cytokine 12 (2000) 1423-1425
29. Willis C., Morris J.M., Danis V., and Gallery E.D.M. Cytokine production by peripheral blood monocytes during the normal human ovulatory menstrual cycle. Hum Reprod 18 (2003) 1173-1178
30. Salkeld B.D., MacAulay J.C., Ball R.W., and Cannon J.G. Modulation of body temperature, interleukin-6 and leptin by oral contraceptive use. Neuroimmunomodulation 9 (2001) 319-325